[Evaluation of aptine, a new adrenergic beta blockader, in angina pectoris].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000526:Alprenolol / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D008297:Male; D010919:Placebos
D000319:Adrenergic beta-Antagonists; D010919:Placebos; D000526:Alprenolol
Evaluation de l'aptine un nouveau bloqueur adrénergique bèta dans l'angine de poitrine.